Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
4.670
-0.240 (-4.89%)
Apr 13, 2026, 4:00 PM EDT - Market closed
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $8.97 million as of April 13, 2026. Its market cap has decreased by -46.80% in one year.
Market Cap
8.97M
Enterprise Value
4.74M
1-Year Change
-46.80%
Ranking
Category
Stock Price
$4.67
Market Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $8.97M, a decrease of -98.70%. That is a compound annual growth rate of -56.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 9.43M | -10.11% |
| Dec 31, 2025 | 10.50M | -48.75% |
| Dec 31, 2024 | 20.48M | -51.84% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quoin Pharmaceuticals | 10.64M |
| Theriva Biologics | 10.59M |
| Aprea Therapeutics | 10.50M |
| Genprex | 10.40M |
| BioVie | 10.18M |
| Reviva Pharmaceuticals Holdings | 9.88M |
| Hoth Therapeutics | 9.86M |
| CalciMedica | 9.73M |